IFNG and neoplasm: Taken together, these results indicated that sequential treatment of sNK cells with anti-PD-1 antibody is capable of increasing cytotoxic function in tumor-implanted hu-BLT mice and significantly augmented the secreted IFN-γ in immune cells from bone marrow, spleen and peripheral blood.